Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993

Bibliographic Information

Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993

edited by Graham A. MacGregor, Peter S. Sever ; associate editor, David Caldwelkl ; foreword by Joel Menard

Churchill Livingstone, 1993

Available at  / 1 libraries

Search this Book/Journal

Description and Table of Contents

Description

Contains the proceedings of the Third International Symposium on ACE Inhibition (Amsterdam 19-23 March 1993). This book represents an update on issues relating to ACE inhibition. It also provides information relating to current research and developments in the field.

Table of Contents

  • THE VASCULATURE: Hypertensive vascular disease - pathophysiological mechanisms
  • The role of angiotensin II and other growth factors in vascular hypertrophy
  • Vascular remodelling: a role for ACE inhibitors?. THE HEART: From hypertension to hypertrophy - molecular and cellular mechanisms
  • The renin-angiotensin system, the heart and the genesis of arrhythmias
  • What is the mechanism by which ACE inhibitors reduce mortality in heart failure?
  • Left ventrical structural remodelling - potential for therapeutic intervention
  • Is the ACE insertion/deletion polymorphism a risk factor for myocardial infarction? THE KIDNEY: Intrarenal actions of angiotensin II: role in health and disease
  • Inhibition of renin-angiotensin system and its effects on renal function - experimental evidence
  • Do ACE inhibitors preserve renal function in man?
  • The role of ACE inhibitors in patients with renal disease
  • Renovascular hypertension - the role of ACE inhibitors. CLINICAL PHARMACOLOGY: Differences between ACE inhibitors - are any of clinical relevance?
  • ACE inhibitors - concentration effect, dose response and duration of action in man
  • Indications for ACE inhibitors in the treatment of hypertension. OTHER INHIBITORS OF THE RENIN SYSTEM: Molecular and regulatory aspects of ACE - new developments
  • Localisation of angiotensin II receptors in various tissues
  • Differences between angiotensin II antagonists
  • Clinical evaluation of AII antagonists in hypertension
  • Renin inhibitors
  • Renin-angiotensin system inhibition: which intervention site should be targeted?. GENERAL: Diabetes - long-term renal protection - specific benefits from ACE inhibitors
  • Long-term renal protection - specific benefits from ACE inhibitors - the case for and against
  • Future use of ACE inhibitors.

by "Nielsen BookData"

Details

  • NCID
    BA23291631
  • ISBN
    • 0443051410
  • Country Code
    uk
  • Title Language Code
    eng
  • Text Language Code
    eng
  • Place of Publication
    Edinburgh
  • Pages/Volumes
    xx, 231 p.
  • Size
    26 cm
  • Classification
Page Top